Document Detail


Direct thrombin inhibitors' potential efficacy in Alzheimer's disease.
MedLine Citation:
PMID:  23144146     Owner:  NLM     Status:  In-Data-Review    
Abstract/OtherAbstract:
Alzheimer's disease (AD) is a neurodegenerative disease with no available disease-modifying drugs. However, it has been postulated that neurovascular damage is a primary occurrence in this disease. Neurovascular damage is the result of the presence of cardiovascular risk factor generating hypoxia, oxidative stress, and metabolic changes that activate the endothelial cells of the brain microvasculature in order to respond to the stress by the development of angiogenesis. This endothelial activation could lead to a secretion of many proinflammatory cytokines and growth factors, such as thrombin. Heparin and related oligosaccharides have been shown to be efficient in the improvement of symptoms of AD. Their efficacy may be limited by their nonselective inhibitory effect of thrombin's activity. Direct thrombin inhibitors, such as dabigatran, might be efficient in the treatment of patients with AD because of their high selectivity for thrombin's activity inhibition while having a safer side effects profile than heparin.
Authors:
Bou Khalil Rami
Related Documents :
11950116 - Clinical outcome of invasive pneumococcal infection in children: a 10-year retrospectiv...
15763346 - Heme oxygenase-1 levels and oxidative stress-related parameters in non-alcoholic fatty ...
11530336 - Alcoholic liver disease: new insights into mechanisms and preventative strategies.
7908196 - Clinical significance of measuring plasma concentrations of glutamine and glutamate in ...
19403056 - Chronic obstructive pulmonary disease: evidence for an autoimmune component.
1277546 - Direct measurement of serum non-caeruloplasmin copper in liver disease.
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  American journal of Alzheimer's disease and other dementias     Volume:  27     ISSN:  1938-2731     ISO Abbreviation:  Am J Alzheimers Dis Other Demen     Publication Date:  2012 Dec 
Date Detail:
Created Date:  2012-11-12     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101082834     Medline TA:  Am J Alzheimers Dis Other Demen     Country:  United States    
Other Details:
Languages:  eng     Pagination:  564-7     Citation Subset:  IM    
Affiliation:
Psychiatric Hospital of the Cross, Saint Joseph University, Beirut, Lebanon.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  A new, sensitive marine microalgal recombinant biosensor using luminescence monitoring for toxicity ...
Next Document:  Predicting attendance at dementia family support groups.